ATC code C05
| ATC codes | |||
|---|---|---|---|
| C Cardiovascular system | |||
| C01 Cardiac therapy | |||
| C02 Antihypertensives | |||
| C03 Diuretics | |||
| C04 Peripheral vasodilators | |||
| C05 Vasoprotectives | |||
| C07 Beta blocking agents | |||
| C08 Calcium channel blockers | |||
| C09 Agents acting on the renin-angiotensin system | |||
| C10 Lipid modifying agents | |||
|
| |||
ATC code C05 Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC05...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C05A Agents for treatment of hemorrhoids and anal fissures for topical use
C05AA Corticosteroids
- C05AA01 Hydrocortisone
- C05AA04 Prednisolone
- C05AA05 Betamethasone
- C05AA06 Fluorometholone
- C05AA08 Fluocortolone
- C05AA09 Dexamethasone
- C05AA10 Fluocinolone acetonide
- C05AA11 Fluocinonide
- C05AA12 Triamcinolone
C05AD Local anesthetics
- C05AD01 Lidocaine
- C05AD02 Tetracaine
- C05AD03 Benzocaine
- C05AD04 Cinchocaine
- C05AD05 Procaine
- C05AD06 Oxetacaine
- C05AD07 Pramocaine
C05AE Muscle relaxants
- C05AE01 Glyceryl trinitrate
- C05AE02 Isosorbide dinitrate
- C05AE03 Diltiazem
C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
- C05AX01 Aluminium preparations
- C05AX02 Bismuth preparations, combinations
- C05AX03 Other preparations, combinations
- C05AX04 Zinc preparations
- C05AX05 Tribenoside
C05B Antivaricose therapy
C05BA Heparins or heparinoids for topical use
- C05BA01 Organo-heparinoid
- C05BA02 Sodium apolate
- C05BA03 Heparin
- C05BA04 Pentosan polysulfate sodium
- C05BA51 Heparinoid, combinations
- C05BA53 Heparin, combinations
C05BB Sclerosing agents for local injection
- C05BB01 Monoethanolamine oleate
- C05BB02 Polidocanol
- C05BB03 Invert sugar
- C05BB04 Sodium tetradecyl sulfate
- C05BB05 Phenol
- C05BB56 Glucose, combinations
C05BX Other sclerosing agents
- C05BX01 Calcium dobesilate
- C05BX51 Calcium dobesilate, combinations
C05C Capillary stabilising agents
C05CA Bioflavonoids
- C05CA01 Rutoside
- C05CA02 Monoxerutin
- C05CA03 Diosmin
- C05CA04 Troxerutin
- C05CA05 Hidrosmin
- C05CA51 Rutoside, combinations
- C05CA53 Diosmin, combinations
- C05CA54 Troxerutin, combinations
C05CX Other capillary stabilising agents
- C05CX01 Tribenoside
- C05CX02 Naftazone
- C05CX03 Hippocastani semen
References
- ↑ "ATC/DDD Index 2016: code C05". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QC05". WHO Collaborating Centre for Drug Statistics Methodology.
| ||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, January 09, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.